Please login to the form below

Not currently logged in

Wave Healthcare makes five new appointments

Boosts its programmes and editorial teams

Wave Healthcare

Pictured from left: Helen Sheppard, Eva Raebel, Gabriel Cordel, Liz Williams and Charlotte Wilkinson

UK-based Wave Healthcare Communications has made three new appointments to its programmes team and two to its editorial team.

Helen Sheppard joins Wave Healthcare as programme director, bringing experience in medical education from Fishawack Communications where she served most recently as an account director.

Returning to the medical education agency, Charlotte Wilkinson takes up the role of programme manager having spent six months at Synergy Medical as an account manager.

Liz Williams also joins the programmes team as a programme executive and brings experience in logistics planning.

Meanwhile, Wave Healthcare has also appointed Gabriel Cordel as its new medical writer and Eva Raebel as editorial assistant.

Cordel brings experience in proofreading and editing international medical journals as well as content development, while Raebel has experience editing and writing for Oxford University Press publications.

Roderick Ball, co-owner and director of Wave Healthcare, said: “We are delighted with the expertise and experience of our new programme and editorial team appointments, coming as they do at a time of exciting growth for Wave.”

17th February 2016

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Revisiting Instagram for pharma
In pharma, Instagram usage is increasing because it offers so many benefits to engage with patients and HCPs...
The one multichannel question you must ask
There is a question every marketer should ask when designing a multichannel communications strategy...
Medius Deal Watch
Deal Watch September 2016
Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up...